COLL vs LOW
Collegium Pharmaceutical Inc (COLL) versus Lowe's Companies Inc (LOW) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Lowe's Companies Inc (LOW) is a home improvement retail company listed on NYSE.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported LOW revenue for 2026-01-30 was $86.29B. Net income was $6.65B. Revenue was up 3.1% from 2025-01-31 to 2026-01-30. LOW currently screens at market cap $121.89B and trailing P/E 18.4.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. LOW currently screens at market cap $121.89B and trailing P/E 18.4.
Not investment advice. Open the COLL and LOW stock pages for the full models.
Not investment advice.